Back

effectiveness and safety of reduced dose of direct oral anticoagulants in real world practice in asia

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Atrial Fibrillation - Stroke Prevention Oral Anticoagulation EHRA Premium Access EHRA 2019

About the speaker

Photo
Assistant Professor Kwang-No Lee

Ajou University, Suwon (Korea (Republic of))

9 More presentations in this session

Presentation thumbnail
Atrial fibrillation predictors in patient with embolic strokes of undetermined source
Mr J. Ramos Maqueda (Zaragoza, ES)
Abstract
Presentation thumbnail
Left atrial appendage morphology predicts cardio-embolic stroke due to atrial fibrillation
Doctor A. Adukauskaite (Innsbruck, AT)
Abstract
Presentation thumbnail
Progression and clinical manifestations in screening-detected atrial fibrillation: a five-year follow-up of the STROKESTOP study
Ms F. Liljegren (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Differences in hospitalization frequencies depending on used oral anticoagulant type
Doctor I. Pupkevica (Riga, LV)
Abstract
Presentation thumbnail
Oral anticoagulants and health related quality of life: 6- and 12-month follow-up
Ms K. Grinberga (Riga, LV)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Atrial Fibrillation - Stroke Prevention

The Event

Event poster

EHRA 2019

17 March - 19 March 2019
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on stroke prevention in atrial fibrillation
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - pro
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources